Fig. 6: EBV-miR-BART22 induces β-catenin abnormally activated in the NPC cell lines. | Cell Death & Disease

Fig. 6: EBV-miR-BART22 induces β-catenin abnormally activated in the NPC cell lines.

From: Epstein–Barr virus-encoded microRNA BART22 serves as novel biomarkers and drives malignant transformation of nasopharyngeal carcinoma

Fig. 6

A Pathway based on the KEGG and TargetScan databases. B Pathway based on the KEGG and DIANA databases. C The nuclear fraction of indicated cells was analyzed by WB analysis. D–F Cells were treated with β-catenin siRNA and plasmid β-catenin for 72 h, and then performed wound-healing assays and Transwell/migration assay. *P < 0.05. **P < 0.01. G Expression of epithelial cell marker, mesenchymal cell marker, and β-catenin in indicated cells were examined by WB analysis. GAPDH was used as a loading control.

Back to article page